US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Target Atlas in Brain Cancer: A Competitive Outlook
8/9/2016 | published by: BioSeeker Group AB
... Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Brain Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ...  |  read more...
USD 6,750
Guillain-Barre Syndrome Global Clinical Trials Review, H1, 2016
6/30/2016 | published by: GlobalData
... line data relating to the clinical trials on Guillain-Barre Syndrome. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Partial Seizure Global Clinical Trials Review, H1, 2016
6/30/2016 | published by: GlobalData
... line data relating to the clinical trials on Partial Seizure. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Obsessive-Compulsive Disorder Global Clinical Trials Review, H2, 2016
7/27/2016 | published by: GlobalData
... line data relating to the clinical trials on Obsessive-Compulsive Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Schizoaffective Disorder Global Clinical Trials Review, H2, 2016
7/27/2016 | published by: GlobalData
... line data relating to the clinical trials on Schizoaffective Disorder. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Charcot-Marie-Tooth Disease - Pipeline Review, H2 2016
7/13/2016 | published by: Global Markets Direct
... therapeutics under development for Charcot-Marie-Tooth Disease, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Pontine Glioma Global Clinical Trials Review, H2, 2016
7/29/2016 | published by: GlobalData
... line data relating to the clinical trials on Pontine Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
ADHD Medication Manufacturing - Industry Market Research Report
8/12/2016 | published by: IBISWorld
... a boon to the industry, and healthcare reform has enabled more children to access behavioral health services, resulting in more patients being able to have their ADHD identified and treated. In the five years to ...  |  read more...
USD 1,020
Dementia - Pipeline Review, H2 2016
8/10/2016 | published by: Global Markets Direct
... for Dementia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Global Depressive Disorder Market: Industry Analysis & Outlook (2016-2020)
8/1/2016 | published by: Koncept Analytics
... that causes a persistent feeling of sadness and loss of interest. It builds up a very negative perspective in the way of thinking in every single thing and damages a person’s ability to see brighter ...  |  read more...
USD 800
Acute Sensorineural Hearing Loss - Pipeline Review, H2 2016
7/20/2016 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutics under development for Acute Sensorineural Hearing Loss, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...  |  read more...
USD 2,000
Tourette Syndrome - Pipeline Review, H2 2016
7/20/2016 | published by: Global Markets Direct
... therapeutics under development for Tourette Syndrome, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Obsessive-Compulsive Disorder - Pipeline Review, H2 2016
7/20/2016 | published by: Global Markets Direct
... therapeutics under development for Obsessive-Compulsive Disorder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
Seizures - Pipeline Review, H2 2016
7/20/2016 | published by: Global Markets Direct
... for Seizures, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete ...  |  read more...
USD 2,000
Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016
7/20/2016 | published by: Global Markets Direct
... report provides comprehensive information on the therapeutics under development for Peripheral Neuropathy (Sensory Neuropathy), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The ...  |  read more...
USD 2,000
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H2 2016
8/10/2016 | published by: Global Markets Direct
... pipeline landscape. The report provides comprehensive information on the therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ...  |  read more...
USD 2,000
Alcohol Addiction - Pipeline Review, H2 2016
7/20/2016 | published by: Global Markets Direct
... therapeutics under development for Alcohol Addiction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ...  |  read more...
USD 2,000
U.S. Therapeutic Plasma Exchange Market by Indication (Neurological & Autoimmune Disorders), Procedures & Patients (Guillain Barre Syndrome, Multiple Sclerosis, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura, Glomerulonephritis) - Forecasts to 202
7/19/2016 | published by: MarketsandMarkets
... (TPE) market by indication is estimated to reach USD 260.0 million by 2021, growing at a CAGR of 11% to 12% during the forecast period (2016 to 2021). The rising incidences of blood disorders and ...  |  read more...
USD 5,650
Recurrent Medulloblastoma Global Clinical Trials Review, H2, 2016
7/29/2016 | published by: GlobalData
... line data relating to the clinical trials on Recurrent Medulloblastoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ...  |  read more...
USD 2,500
Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, ...  |  read more...
USD 1,250
Adult Malignant Glioma -Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Anorexia Nervosa-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
Astrocytoma-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ...  |  read more...
USD 1,250
Bipolar Disorder (Manic Depression)-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ...  |  read more...
USD 1,250
Brain Injury-Pipeline Insights, 2016
8/1/2016 | published by: DelveInsight
... development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ...  |  read more...
USD 1,250
1  2    4    6  7  8  9  10